FTC Questions Sandoz-Aurobindo Deal Plans

22.11.2019 - Plans by Swiss drugmaker Novartis to sell $1 billion worth of assets belonging to its Sandoz generics subsidiary to India’s Aurobindo Pharma may run afoul of the US Federal Trade...